z-logo
Premium
Acquired Downregulation of Donor‐Specific Antibody Production After ABO ‐Incompatible Kidney Transplantation
Author(s) -
Tasaki M.,
Saito K.,
Nakagawa Y.,
Imai N.,
Ito Y.,
Aoki T.,
Kamimura M.,
Narita I.,
Tomita Y.,
Takahashi K.
Publication year - 2017
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.13937
Subject(s) - abo blood group system , medicine , downregulation and upregulation , abo incompatibility , kidney transplantation , antibody , transplantation , immunology , donor specific antibodies , surgery , biology , genetics , gene
The mechanism of long‐term B cell immunity against donor blood group antigens in recipients who undergo ABO ‐incompatible ( ABO i) living‐donor kidney transplantation ( LKT x) is unknown. To address this question, we evaluated serial anti‐A and anti‐B antibody titers in 50 adult recipients. Donor‐specific antibody titers remained low (≤1:4) in 42 recipients (84%). However, antibodies against nondonor blood group antigens were continuously produced in recipients with blood type O. We stimulated recipients' peripheral blood mononuclear cells in vitro to investigate whether B cells produced antibodies against donor blood group antigens in the absence of graft adsorption in vivo . Antibodies in cell culture supernatant were measured using specific enzyme‐linked immunosorbent assays ( ELISAs ). Thirty‐five healthy volunteers and 57 recipients who underwent ABO ‐compatible LKT x served as controls. Antibody production in vitro against donor blood group antigens by cells from ABO i LKT x patients was lower than in the control groups. Immunoglobulin deposits were undetectable in biopsies of grafts of eight recipients with low antibody titers (≤1:4) after ABO i LKT x. One patient with blood type A1 who received a second ABO i LKT x from a type B donor did not produce B‐specific antibodies. These findings suggest diminished donor‐specific antibody production function in the setting of adult ABO i LKT x.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom